K. Zoon

发表

Clinical proteomics: translating benchside promise into bedside reality

E. Petricoin, E. Kohn, L. Liotta, 2002, Nature Reviews Drug Discovery.

Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool

Robert J. Fischer, Thomas Hoenen, Heinz Feldmann, 2016, Emerging infectious diseases.

Control of Viral Infections and Diseases

K. Zoon, K. Goldenthal, K. Midthun, 1996 .

Medical applications of microarray technologies: a regulatory science perspective

Emanuel F. Petricoin, Janet Woodcock, Kathryn C. Zoon, 2002, Nature Genetics.

Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer.

R. Puri, Jing Han, S. Hewitt, 2019, Immunotherapy.

BID is a Critical Factor Controlling Cell Viability Regulated by IFN-&agr;

T. Myers, K. Zoon, T. Phillips, 2012, Journal of immunotherapy.

Laboratory Response to 2014 Ebola Virus Outbreak in Mali.

M. Polis, H. Feldmann, T. Schwan, 2016, The Journal of infectious diseases.

Human lymphoblastoid interferon. Large scale production and partial purification.

C. Anfinsen, K. Zoon, U. Rüegg, 1977, The Journal of biological chemistry.

Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.

K. Zoon, Jacquelyn R. Bedsaul, L. A. Zaritsky, 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Report of the international conference on manufacturing and testing of pluripotent stem cells.

Ivana Knezevic, Kapil Bharti, Takao Hayakawa, 2018, Biologicals : journal of the International Association of Biological Standardization.

Cell receptor assays.

K. Zoon, D. zur Nedden, R. Kozak, 1989, Journal of pharmaceutical and biomedical analysis.

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

Robert J. Fischer, T. Nyenswah, J. Strong, 2016, The Journal of infectious diseases.

Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use

K. Zoon, D. Stroncek, C. Annunziata, 2019, Journal of Translational Medicine.

Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.

Robert J. Fischer, T. Nyenswah, J. Strong, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Studies of the interferon receptors.

K. Zoon, H. Arnheiter, 1984, Pharmacology & therapeutics.

Near eradication of clinically relevant concentrations of human tumor cells by interferon-activated monocytes in vitro.

Christopher M. Clark, K. Zoon, S. Baron, 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Clinical model: interferons activate human monocytes to an eradicative tumor cell level in vitro.

K. Zoon, S. Baron, K. Clouse, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Amino terminal sequence of the major component of human lymphoblastoid interferon.

L. Hood, M. Hunkapiller, C. Anfinsen, 1980, Science.

Purification and characterization of human interferon from lymphoblastoid (Namalva) cultures.

K. Zoon, 1981, Methods in enzymology.

Purification and partial characterization of human lymphoblast interferon.

C. Anfinsen, K. Zoon, D. zur Nedden, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Nucleolin Interacts With the Dengue Virus Capsid Protein and Plays a Role in 1

T. Pierson, K. Zoon, S. Ganesan, 2013 .

Nucleolin Interacts with the Dengue Virus Capsid Protein and Plays a Role in Formation of Infectious Virus Particles

T. Pierson, K. Zoon, S. Ganesan, 2013, Journal of Virology.

The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study.

R. Thorpe, A. Mire-Sluis, K. Zoon, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

CHAPTER 26 – Interferon: Past, Present, and Future

K. Zoon, 1984 .

Procedures for measuring receptor-mediated binding and internalization of human interferon.

K. Zoon, H. Arnheiter, D. FitzGerald, 1986, Methods in enzymology.

Human interferon alpha enters cells by receptor-mediated endocytosis.

M. Willingham, K. Zoon, D. zur Nedden, 1983, Virology.

Interferon fever: absence of human leukocytic pyrogen response to recombinant alpha-interferon.

K. Zoon, H. D. Hochstein, B. Elisberg, 1984, Journal of leukocyte biology.

Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1.

B. Murphy, K. Zoon, P. Collins, 2006, Virology.

Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.

Robert J. Fischer, T. Nyenswah, H. Ebihara, 2016, The Journal of infectious diseases.

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak

Robert J. Fischer, T. Nyenswah, J. Strong, 2016, Emerging infectious diseases.

Regulation of Interferon Production by Human Monocytes: Requirements for Priming for Lipopolysaccharide‐Induced Production

K. Zoon, J. Enterline, T. Gerrard, 1991, Journal of leukocyte biology.

Specific binding of human alpha interferon to a high affinity cell surface binding site on bovine kidney cells.

K. Zoon, D. zur Nedden, H. Arnheiter, 1982, The Journal of biological chemistry.

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

L. Sawyer, J. Metcalf, R. Davey, 1989, Annals of internal medicine.

Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses

K. Zoon, J. Djeu, R. Herberman, 1982, The Journal of experimental medicine.

A trial of RSV immune globulin in infants and young children: the FDA's view.

S. Ellenberg, K. Zoon, J. Epstein, 1994, The New England journal of medicine.

Biologic activity in a fragment of recombinant human interferon alpha.

M. Hunkapiller, K. Zoon, D. zur Nedden, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Evidence for multiple binding sites for several components of human lymphoblastoid interferon-alpha.

K. Zoon, J. Liu, R. Hu, 1993, The Journal of biological chemistry.

Enhancement of monocyte-mediated tumoricidal activity by multiple interferon-α species

D. S. Webb, K. Zoon, Dorothea M. Miller, 1989 .

Differential effects of interferon-alpha and interferon-gamma on interleukin 1 secretion by monocytes.

K. Zoon, J. Siegel, T. Gerrard, 1987, Journal of immunology.

Modulation of epidermal growth factor receptors by human alpha interferon.

K. Zoon, Y. Karasaki, D. zur Nedden, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques

Hua Gao, K. Zoon, H. Bays, 1994, Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques.

Products of stimulated monocytes enhance the activity of interferon-gamma.

K. Zoon, J. Enterline, T. Gerrard, 1989, Journal of interferon research.

Chemical and Biological Characterization of Natural Human Lymphoblastoid Interferon Alphas

K. Zoon, J. Manischewitz, J. Enterline, 1987 .

K C Zoon and tumor necrosis factor . alpha interferon , interferon regulatory factors , lipopolysaccharide responses : expression of Priming of human monocytes for enhanced

K. Zoon, 2003 .

Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor

K. Zoon, M. Hayes, 1993, Infection and immunity.

Regulation of somatic-cell therapy and gene therapy by the food and drug administration.

K. Zoon, P. Noguchi, D. Kessler, 1993, The New England journal of medicine.

Amino terminus is essential to the structural integrity of recombinant human interferon-gamma.

D. S. Webb, K. Zoon, J. Enterline, 1989, The Journal of biological chemistry.

Multiple Regulatory Events in the Development of Competence for Genetic Transformation in Haemophilus influenzae

K. Zoon, J. J. Scocca, M. Habersat, 1975, Journal of bacteriology.

Interferon Fever: Absence of Human Leukocytic Pyrogen Response to Recombinant α‐Interferon

K. Zoon, H. D. Hochstein, B. Elisberg, 1984 .

Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes

K. Zoon, Jacquelyn R. Bedsaul, L. A. Zaritsky, 2015, Journal of Virology.

Definition of a well-characterized biotechnology product.

K. Zoon, R. Garnick, 1998, Developments in biological standardization.

Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN.

E. Petricoin, K. Zoon, J. Bekisz, 1999, Journal of immunology.

Hybrid IFN Biological Responses to Recombinant Human Divergence of Binding, Signaling, and

K. Zoon, M. Hayes, J. Bekisz, 1999 .

Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2.

K. Zoon, P. Brown, I. Gorshkova, 2007, Biochemistry.

Purification and characterization of a human Mx protein.

K. Zoon, H. Arnheiter, J. Bekisz, 1989, Journal of interferon research.

Immunological Activities of Recombinant Interferon-α2 and Its A Fragment

K. Zoon, A. Metwali, T. Fleisher, 1987 .

Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1).

M. Wadhwa, P. Dilger, A. Heath, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Phorbol ester and interferon-gamma modulation of epidermal growth factor receptors on human amniotic (WISH) cells.

K. Zoon, Y. Karasaki, A. Komoriya, 1989, The Journal of biological chemistry.

Characterization of interferon messenger RNA synthesis in Namalva cells.

R. Friedman, K. Zoon, E. Chang, 1980, The Journal of biological chemistry.

Human interferons alpha, beta and omega.

K. Zoon, Hana Schmeisser, Joseph Bekisz, 2004, Growth factors.

Monocyte and interferon based therapy for the treatment of ovarian cancer.

K. Zoon, C. Annunziata, D. Green, 2016, Cytokine & growth factor reviews.

Cytokine & Growth Factor Reviews

K. Zoon, C. Annunziata, D. Green, 2016 .

Production and action of interferons: new insights into molecular mechanisms of gene regulation and expression.

K. Zoon, M. Hayes, 1994, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Interferons and their actions.

K C Zoon, J A Langer, S Pestka, 1987, Annual review of biochemistry.

The interferon receptors

K. Zoon, M. Rubinstein, P. Orchansky, 1986 .

Standardization of Human IL-29 (IFN- l 1): Establishment of a World Health Organization International Reference Reagent for IL-29 (IFN- l 1) Participants of the Collaborative Study

M. Wadhwa, P. Dilger, A. Heath, 2014 .

Plasma membrane biophysical properties linked to the antiproliferative effect of interferon-alpha.

K. Zoon, A. Aszalos, E. Bálint, 2005, Acta microbiologica et immunologica Hungarica.

Prolonged STAT1 activation related to the growth arrest of malignant lymphoma cells by interferon-alpha.

E. Petricoin, K. Zoon, F. Dong, 1998, Blood.

Prolonged STAT 1 Activation Related to the Growth Arrest of Malignant Lymphoma Cells by Interferon-a By

E. Petricoin, H. Rui, K. Zoon, 1998 .

Oligo(2'-5')adenylate synthetase in human lymphoblastoid cells.

E. De Clercq, R. Friedman, K. Zoon, 1980, Biochemical and biophysical research communications.

Purification and characterization of multiple components of human lymphoblastoid interferon-alpha.

K. Zoon, J. Enterline, D. zur Nedden, 1992, The Journal of biological chemistry.

Comparative Structures of Mammalian Interferons

K. Zoon, R. Wetzel, 1984 .

Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors

R. Puri, K. Zoon, S. Baron, 2012, Cancer Immunology, Immunotherapy.

New function of type I IFN: induction of autophagy.

K. Zoon, H. Schmeisser, J. Bekisz, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer

S. Steinberg, K. Zoon, D. Stroncek, 2018, Journal of Translational Medicine.

Hypotension and bedside leukocyte reduction filters.

K. Zoon, J. Woodcock, E. Jacobson, 1999, International journal of trauma nursing.

Identification of Alpha Interferon-Induced Genes Associated with Antiviral Activity in Daudi Cells and Characterization of IFIT3 as a Novel Antiviral Gene

K. Zoon, J. Mejido, H. Schmeisser, 2010, Journal of Virology.

Mini ReviewHuman Interferons Alpha, Beta and Omega

Kathryn C. Zoon, Neil Goldman, K. Zoon, 2004 .

Mutation rate and genotype variation of Ebola virus from Mali case sequences

K. C. Zoon, K. Wollenberg, H. Ebihara, 2015, Science.

Immunomodulatory effects of interferons in malignancies.

R. Puri, K. Zoon, S. R. Husain, 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Human IFN-α Protein Engineering: The Amino Acid Residues at Positions 86 and 90 Are Important for Antiproliferative Activity1

K. Zoon, H. Schmeisser, P. McPhie, 2001, The Journal of Immunology.

Are Important for Antiproliferative Activity Amino Acid Residues at Positions 86 and 90 Protein Engineering : The α Human IFN-and

K. Zoon, H. Schmeisser, P. McPhie, 2001 .

Specificity in Deoxyribonucleic Acid Uptake by Transformable Haemophilus influenzae

K. Zoon, J. J. Scocca, R. L. Poland, 1974, Journal of bacteriology.

Effects of interferon-alpha in patients with AIDS-associated Kaposi's sarcoma are related to blood interferon levels and dose.

L. Sawyer, J. Metcalf, J. Kovacs, 1990, Cytokine.

Human monocytes in the presence of interferons alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatin.

K. Zoon, D. Green, Chase L. Johnson, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells.

K. Zoon, Kotaro Miyake, T. Zhao, 2012, Biochimica et biophysica acta.

IRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-α

K. Zoon, J. Mejido, H. Schmeisser, 2009, Journal of immunotherapy.

Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN.

E. Petricoin, K. Zoon, J. Bekisz, 1999, Journal of immunology.

Specificity inDeoxyribonucleic AcidUptake byTransformable Haemophilus influenzae

K. Zoon, J. J. Scocca, R. L. Poland, 1974 .

Synthesis of envelope polypeptides by Haemophilus influenzae during development of competence for genetic transformation

K. Zoon, J. J. Scocca, M. Habersat, 1976, Journal of Bacteriology.

Constitution of the cell envelope of Haemophilus influenzae in relation to competence for genetic transformation

K. Zoon, J. J. Scocca, 1975, Journal of bacteriology.

Radiolabeling of human interferon alphas with 125I-labeled Bolton-Hunter reagent.

K. Zoon, D. zur Nedden, 1986, Methods in enzymology.

A set of aspartyl protease-deficient strains for improved expression of heterologous proteins in Kluyveromyces lactis

J. Hartley, D. Esposito, K. Zoon, 2010, FEMS yeast research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Antiproliferative Properties of Type I and Type II Interferon

K. Zoon, S. Baron, C. Balinsky, 2010, Pharmaceuticals.

Announcement: interferon nomenclature.

R. Friedman, K. Zoon, J. Blalock, 1980, International journal of immunopharmacology.

Structural variants of IFNα preferentially promote antiviral functions.

Michael A Dolan, K. Zoon, S. Wahl, 2011, Blood.

Ernest (Pete) Knight Jr. (1932-2013). A remembrance to a great interferon scientist and colleague.

K. Zoon, 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Human leukocyte-derived alpha-interferons: purification and amino-terminal-amino-acid sequence of two components.

M. Hunkapiller, K. Zoon, D. zur Nedden, 1982, Journal of interferon research.

Multiple biological activities of homogeneous human alpha interferon

K. Zoon, J. Huntington, A. Attallah, 1981, Infection and immunity.

Large-Scale Production and Concentration of Human Lymphoid Interferon

K. Zoon, W. I. Jones, F. Klein, 1979, Antimicrobial Agents and Chemotherapy.

Modulation of epidermal growth factor receptors by human a interferon ( down regulation / bovine kidney cells )

K. Zoon, Y. Karasaki, Dorothy L. Zur, 1999 .

Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.

K. Zoon, R. Blaese, G. Tosato, 1987, The Journal of clinical investigation.

Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-gamma.

K. Zoon, D. zur Nedden, J. Siegel, 1988, Journal of immunology.

Important drug warning: Immune Globulin Intravenous (human) (IGIV) products.

K. Zoon, J. Epstein, 2000, Neonatal network : NN.

Orientation of a human leukocyte interferon molecule on its cell surface receptor: carboxyl terminus remains accessible to a monoclonal antibody made against a synthetic interferon fragment.

K. Zoon, B. Gutte, H. Arnheiter, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of the steady state binding, internalization, and degradation of human interferon-alpha2.

K C Zoon, K. Zoon, D. zur Nedden, 1986, The Journal of biological chemistry.

High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4.

J. Coligan, W. Paul, K. Zoon, 1987, Journal of immunology.

Type I interferons induce autophagy in certain human cancer cell lines

K. Zoon, E. Fischer, A. Snow, 2013, Autophagy.

A Novel Role for IFN-Stimulated Gene Factor 3II in IFN-γ Signaling and Induction of Antiviral Activity in Human Cells

K. Zoon, H. Schmeisser, Takaya Tsuno, 2011, The Journal of Immunology.

Purification and partial characterization of human lymphoblastoid interferon

C. Anfinsen, K. Zoon, Mark E. Smith, 2022 .

IRAV (FLJ11286), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, Interacts with MOV10

K. Zoon, S. Ganesan, T. Jin, 2016, Journal of Virology.

Future Directions in Cancer Research: Impact of the Completion of the Human Genome

K. Zoon, 2004, Toxicologic pathology.

Binding Characteristics of IFN-α Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag

D. Esposito, K. Zoon, G. Schreiber, 2006 .

Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag.

D. Esposito, K. Zoon, G. Schreiber, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Gateway cloning is compatible with protein secretion from Pichia pastoris

J. Hartley, D. Esposito, K. Zoon, 2005, Protein Expression and Purification.

S. Steinberg, K. Zoon, D. Stroncek, 2018, Journal of translational medicine.

Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use

K. Zoon, D. Stroncek, C. Annunziata, 2019, Journal of Translational Medicine.

Production of human lymphoblastoid interferon by Namalva cells

K. Zoon, C. Buckler, P. Bridgen, 1978, Journal of clinical microbiology.

WHO Expert Committee on biological standardization.

K. C. Zoon, K. Zoon, 2005, World Health Organization technical report series.

Aurin tricarboxylic acid, the anti-AIDS compound, prevents the binding of interferon-alpha to its receptor.

K. Zoon, J. Weaver, Y. Gan, 1990, Biochemical and Biophysical Research Communications - BBRC.

[45] Procedures for studying the binding of interferon to human and bovine cells in monolayer culture